Hypertension Market Trends, Share, and Forecast By 2030

Comments · 13 Views

Data Bridge Market Research analyses that the hypertension market which was USD 31.76 billion in 2022, is expected to reach USD 43.18 billion by 2030, and is expected to undergo a CAGR of 4.00% during the forecast period of 2023 to 2030

"The rapidly evolving marketplace demands the best market and business solutions to thrive. The  Hypertension Market report contains comprehensive data on market definition, classifications, applications, engagements, market drivers, and market restraints in the Hypertension Market industry, all derived from SWOT analysis. The market definition covered in this market research report gives the scope of a particular product concerning the driving factors and restraints in the market. The sources of data and information mentioned in the Hypertension Market report are very reliable and include websites, annual reports of companies, journals, and mergers, all checked and validated by market experts.

Market definition, market segmentation, key developments in the market, competitive analysis, and research methodology are major topics covered in the reliable Hypertension Market research report, thoroughly studied with the best tools and techniques. This market report consists of historic data alongside future forecasts and detailed analysis on a global and regional level. The insights will guide actionable ideas, better decision-making, and better business strategies. The scope of the Hypertension Market business report can also be extended from market scenarios to comparative pricing between major players, the cost and profit of specified market regions.

The global hypertension drug market growth is driven through primary factors i.e. increase in sudden incidences of hypertension worldwide, people affected by diabetes, improvement in technology, and growing aging population. In addition, rising expenditures on health, an increase in cardiovascular diseases, and growing tobacco users are fuelling the growth of the global market. According to WHO (World Health Organization), more than 1.13 billion people are suffering from hypertension globally, among them, only 1 in each 5 is cured or under control.  WHO also states that in the 21st-century hypertension is one of the silent killers and one of the largest concerns of public health.

Data Bridge Market Research analyses that the hypertension market which was USD 31.76 billion in 2022, is expected to reach USD 43.18 billion by 2030, and is expected to undergo a CAGR of 4.00% during the forecast period of 2023 to 2030. “Hospitals” dominates the end user segment of the global hypertension market owing to the growing demand for drug. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Explore Further Details about This Research Hypertension Market Report https://www.databridgemarketresearch.com/reports/global-hypertension-market

REPORT METRIC

DETAILS

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

By Type (Primary Hypertension, Secondary Hypertension, Others), Measurement Categories (Normal Blood Pressure, Elevated Blood Pressure, Stage 1 Hypertension, Stage 2 Hypertension, Others), Treatment (Medication, Additional Therapy, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

F. Hoffmann-La Roche Ltd (Switzerland), Fresenius Kabi AG (Germany), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Zydus Group (India), Pfizer Inc. (U.S.), Lupin (India), GSK Plc (U.K.), Glenmark Pharmaceuticals Inc. (India), Wockhardt (India)

Market Opportunities

  • Increased clinical studies and government initiatives
  • Rising prevalence of hypertension
  • Increasing demand for retail pharmacies

Market Definition

Hypertension or elevated blood pressure that causes severe medical conditions significantly increases the risks of heart, brain, and kidney diseases. Blood pressure is denoted as two numbers: systolic blood pressure, which represents pressure in blood vessels when the heart contracts or beats, and diastolic blood pressure, which represents the pressure in the vessels when the heart rests between beats. The normal blood pressure is 120/80 mm Hg. 

Global Hypertension Market Dynamics

Drivers

  • Increase in Cardiovascular Diseases

According to the WHO, about 60% - 85% of the population have adopted a sedentary life. According to CDC, nea​​​​​​​rly 31 million adults aged over 50 years live a sedentary life, and only 1 out of 4 U.S. adults meet the appropriate need for physical activity. This boost the market growth.

  • Rising FDA Approvals

The persistent product approvals are projected to boost market growth. For instance, in May 2022, Zydus Lifesciences Limited's subsidiary received tentative approval from the U.S. FDA to market Selexipag tablets which are used to treat pulmonary arterial hypertension (PAH) in adults. In February 2022, the FDA approved the Norliqva (amlodipine) oral solution to treat hypertension in adults and children six years or older to lower blood pressure and coronary artery disease.

  • Rising Prevalence of Hypertension

As per the American College of Cardiology, older adults are mostly undertreated for high blood pressure, despite having the maximum incidence of hypertension and the highest risk of CV morbidity and mortality (B.P.). According to the National Health and Nutrition Examination Survey (NHANES) records in the U.S., hypertension affects 70% of persons over 65. As our population ages, this figure will continue to rise. This will create more opportunities for market growth as the demand for blockers increases.

Opportunity

  • Increasing Demand for Retail Pharmacies

The rise in the number of hypertension drugs delivered through retail pharmacies and the rise in the number of retail pharmacies in highly developed countries can create opportunities for market growth.  In addition, patients prefer retail pharmacies for purchasing drugs, as these are easily available such as increasing applications will create lucrative opportunities in the market, thereby supplementing the market growth.

This comprehensive report provides:

  • Improve strategic decision making
  • Research, presentation and business plan support
  • Show emerging  Hypertension Market opportunities to focus on
  • Industry knowledge improvement
  • It provides the latest information on important market developments.
  • Develop an informed growth strategy.
  • Build technical insight
  • Description of trends to exploit
  • Strengthen competitor analysis
  • By providing a risk analysis, you can avoid pitfalls that other companies may create.
  • Ultimately, you can maximize your company's profitability.

Browse Related Reports:

Diaphragm Pacing Device  Market to Perceive Prominent Growth of Billion by Size, Share, Trends, Demand, Growth and Competitive Analysis

https://www.databridgemarketresearch.com/reports/global-diaphragm-pacing-device-market

Disinfecting Port Protectors  Market Forecasted to Exhibit an Incredible Growth of Billion by Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-disinfecting-port-protectors-market

Femoral Canal Brush  Market Anticipated to Garner Significant Growth of Billion By Size, Share, Trends, Opportunities, Key Drivers, and Revenue Forecast

https://www.databridgemarketresearch.com/reports/global-femoral-canal-brush-market

Hospital ICU Beds  Market Poised to Achieve Exponential CAGR Growth by Size, Share, Trends, Opportunities, Key Drivers, and Revenue Forecast

https://www.databridgemarketresearch.com/reports/global-hospital-icu-beds-market

Hybrid Positron Emission Tomography (PET) Systems  Market to Notice Prominent CAGR Growth by Size, Share, Trends, Demand, Growth and Competitive Outlook

https://www.databridgemarketresearch.com/reports/global-hybrid-positron-emission-tomography-pet-systems-market

Orchiectomy  Market to Observe Utmost Growth of Billion by Size, Share, Trends, Demand, Key Players and Growth Factors

https://www.databridgemarketresearch.com/reports/global-orchiectomy-market

Protective Goggles for Medical  Market is Probable to Influence the Value of Billion by Size, Share, Trends, Growth and Competitive Outlook

https://www.databridgemarketresearch.com/reports/global-protective-goggles-for-medical-market

Ureteroscopes  Market is Likely to Upsurge at Billion Globally by  Size, Share, Trends, Demand, Growth and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-ureteroscopes-market

Endotracheal and Tracheal Suction  Market To Perceive Highest Growth of Billion by Size, Share, Trends, Key Growth Drivers and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-endotracheal-tracheal-suction-market

Handheld Intraoral Dental 3D Scanners  Market to Receive Billion by Size, Shares, Trends, Demand, Growth Opportunities and Revenue Analysis

https://www.databridgemarketresearch.com/reports/global-handheld-intraoral-dental-3d-scanners-market

About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com

 

Comments